Jean-Baptiste Arlin

Title: The Innovations of Jean-Baptiste Arlin

Introduction

Jean-Baptiste Arlin is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of beta-lactamase inhibitors. With a total of 3 patents to his name, Arlin's work is recognized for its potential impact on treating bacterial infections.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereof." This patent describes crystalline forms of (R)-3-(2-(trans-4-(2-aminoethylamino)cyclohexyl)acetamido)-2-hydroxy-3,4-dihydro-2H-benzo[e][1,2]oxaborinine-8-carboxylic acid. In various embodiments, these crystalline forms are formulated for treating subjects in need of intervention for bacterial infections.

Career Highlights

Jean-Baptiste Arlin is currently associated with Venatorx Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on developing effective treatments that address critical health challenges posed by bacterial infections.

Collaborations

Arlin collaborates with esteemed colleagues, including Christopher J. Burns and Daniel C. Pevear. These partnerships enhance the research and development efforts at Venatorx Pharmaceuticals, Inc., fostering an environment of innovation and discovery.

Conclusion

Jean-Baptiste Arlin's contributions to the field of pharmaceuticals through his patents and collaborations highlight his commitment to advancing medical science. His work is poised to make a significant difference in the treatment of bacterial infections.